Real-time trade and investing ideas on Pulmatrix, Inc. PULM from the largest community of traders and investors. ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Pulmatrix, Inc. Common Stock (PULM) Analyst Research | Nasdaq

Pulmatrix, Inc., a clinical stage biopharmaceutical company, develops inhaled therapies to address serious pulmonary diseases using its inhaled Small Particles … PULMATRiX Jul 17, 2018 · The Pulmatrix Pulmazole program is the first inhaled dry powder version of itraconazole known to the company to be advanced into clinical development, with the goal of improving upon the known safety and efficacy profile associated with oral Sporanox by … Pulmatrix Stock Price History + Charts (PULM) • Dogs of ... The following presents a detailed Pulmatrix stock price history for your review. To help provide a sense of the short to long-term trend, included is an interactive Pulmatrix stock chart which you can easily adjust to the time frame of your choosing (e.g. using the scroll bar or pinch and zoom on a touch screen). PULM - Pulmatrix, Inc. Summary, Stock Quote and News ... Jan 01, 2010 · Pulmatrix Q4 EPS $(0.16) Up From $(4.56) YoY, Sales $1.685M Benzinga Newsdesk Thu, 26 Mar 2020 09:06:51 -0400; Shares of several healthcare companies are trading higher as …

When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.

4 days ago Perusahaan Perseroan (Persero) PT Telekomunikasi Indonesia Tbk (TLK): Stock Analysis Review. Investorwelcometeam 12 hours ago 5 min  24 Aug 2019 Learn how to read stock charts and identify technical patterns as ClayTrader does a quick stock chart review on Pulmatrix, Inc. (PULM). Salary, bonuses, stock options, stock awards and other compensation information for top executives at PULMATRIX INC. 2 Jan 2020 Pulmatrix (PULM) Announces Kinase Inhibitor Licensing Agreement with Article Related Press Releases (1) Related Articles (1) Stock Quotes (1) Comments (2) Pulmatrix, Inc. (NASDAQ: PULM), a clinical stage biopharmaceutical i read a lot of positive reviews from patients who used the treatment  26 Mar 2020 "2019 was a transformative year at Pulmatrix marked by significant clinical Preferred stock, $0.0001 par value — 500,000 shares authorized;  PDUFA date under priority review for sNDA April 2020. 5.5b, $186.5b, 1.49, 23m, 36.7m, 0.62, $2.95, $35.00, $34.57, 12/18/2019.

PULM - Stock quote for PULMATRIX, INC. - MSN Money

A free inside look at Pulmatrix salary trends based on 12 salaries wages for 10 jobs at Pulmatrix. Salaries posted anonymously by Pulmatrix employees. PULM Stock | PULMATRIX Stock Price Today | Markets Insider PULM: Get the latest Pulmatrix stock price and detailed information including PULM news, historical charts and realtime prices. Daily Technical Summary Reports on Biotech Stocks ... Aug 24, 2017 · Pulmatrix Lexington, Massachusetts headquartered Pulmatrix Inc.'s stock finished yesterday's session 2.47% higher at $1.74 with a total trading volume of … PULM Pulmatrix, Inc. Stock Quote

Real-time trade and investing ideas on Pulmatrix, Inc. PULM from the largest community of traders and investors. ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal.

TECHNICAL ANALYSIS. Daily; Weekly; Monthly. TECHNICAL RATING. Pulmatrix, Inc. (PULM) Stock Price, Quote, History & News ... Find the latest Pulmatrix, Inc. (PULM) stock quote, history, news and other vital information to help you with your stock trading and investing. PULM Stock Price, Forecast & News (Pulmatrix) | MarketBeat Pulmatrix's stock reverse split on the morning of Wednesday, February 6th 2019. The 1-10 reverse split was announced on Tuesday, February 5th 2019. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, February 5th 2019. An investor that had 100 shares of Pulmatrix stock prior to the reverse split would PULM Pulmatrix, Inc. — Stock Price and Discussion | Stocktwits Real-time trade and investing ideas on Pulmatrix, Inc. PULM from the largest community of traders and investors. ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal.

PULM: Get the latest Pulmatrix stock price and detailed information including PULM news, historical charts and realtime prices.

PULMATRiX With iSPERSE ™ technology, PULMATRiX is expanding therapeutic care for patients with serious disease through a new generation of PULMONARY-DELIVERED THERAPEUTICS. Pulmatrix, Inc. (PULM) Stock Analysis & News | Seeking Alpha Get breaking news and analysis on Pulmatrix, Inc. (PULM) stock, price quote and chart, trading and investing tools. Pulmatrix nabs accelerated review status in U.S. for itraconazole.

Jan 01, 2010 · Pulmatrix Q4 EPS $(0.16) Up From $(4.56) YoY, Sales $1.685M Benzinga Newsdesk Thu, 26 Mar 2020 09:06:51 -0400; Shares of several healthcare companies are trading higher as … PULM - Pulmatrix Stock Analyst Ratings - Barchart.com Analyst Ratings for Pulmatrix Inc (PULM) provide recommendations made by outside industry experts. Analyst Ratings for Pulmatrix Inc (PULM) provide recommendations made by outside industry experts. The information presented on the graph represents the number of industry analysts that currently rank the stock on the 1 to 5 scale. The greater Pulmatrix, Inc. - PULM - Stock Price Today - Zacks View Pulmatrix, Inc. PULM investment & stock information. Get the latest Pulmatrix, Inc. PULM detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. PULM: Message Board for Pulmatrix, Inc. - InvestorVillage Pulmatrix, Inc. Message board - Online Community of active, educated investors researching and discussing Pulmatrix, Inc. Stocks.